Metagenomi Therapeutics (MGX) - Bozor qiymatining balans qiymatiga nisbati

MGX (Metagenomi, Inc.) - kompaniyaning tovar belgisi

GURU.Markets platformasidagi Metagenomi, Inc. (MGX) bozor narxi grafigi aktivning dinamikasini ko'rsatadi va uning qiymati 0.27 ni tashkil etadi. Metagenomi, Inc. (MGX) o'z laboratoriyalarida asosiy ekologik standartlarga rioya qiladi. Biznes tabiiy ma'lumotlarning AI tahlili orqali genom tahrirlashning yangi vositalarini kashf etishga tayanadi, bu esa sezilarli narx belgilash imkoniyatini ta'minlaydi. Strategik ittifoqlar orqali royalti daromadlarini keltiruvchi shaxsiy ferment kutubxonalari o'sish uchun asos bo'lib xizmat qiladi.

Metagenomi, Inc. (MGX) - Bozor kapitallashuvining balans qiymatiga nisbati 21.02.2024dan 29.10.2026gacha

Metagenomi, Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi Metagenomi, Inc.|MGX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Metagenomi, Inc|MGX - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Metagenomi|MGX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati metagenomi.co|MGX - Kompaniyaning yakuniy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Metagenomi, Inc.|MGX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Metagenomi, Inc|MGX - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Metagenomi, Inc|MGX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Metagenomi
Kompaniyaning fundamental baholanishi:Metagenomi, Inc. - MGX
Metagenomi Therapeutics yetakchi tovari

Metagenomi, Inc. (MGX) genom tahrirlash vositalarini ishlab chiqish jarayoni intellektual mulki qiymatiga tayanadi. Ushbu ko'rsatkich aksiyalarining bozor qiymatini sof kapital bilan solishtirib, aktivlarning haddan tashqari qimmat yoki arzon baholanganligini aniqlaydi. Narxning buxgalteriya qiymatiga nisbati tendentsiyasini tahlil qilish orqali investor biznesning haqiqiy qiymatini uning buxgalteriya ko'rsatkichlariga nisbatan aniqlay oladi. Grafikdagi yuqori tebranishlar gen terapiyasi bo'yicha spekulyativ kutishlarni aks ettiradi. Ushbu tendentsiya kompaniyaning biofarmatsevtika ishlanmalari salohiyati bo'yicha bozor konsensusini ifodalaydi.

Raqobatchilar tahlili

TEM: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati QGEN|Bozor qiymatining balans qiymatiga nisbati Ionis|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRISPR (CRSP)|Bozor qiymatining balans qiymatiga nisbati GeneDx Holdings Corp. WGS|RARE - Kapitallashuvning sof aktivlarga nisbati|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Sarepta Therapeutics|TWST (Twist Bio) - Kapitallashuvning sof aktivlarga nisbati|TXG: Bozor kapitallashuvining balans qiymatiga multiplikatori|NTLA (Intellia Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati stoketherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati BLFS|Wave Life Sciences Ltd (WVE) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Sionna Corp (SION) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PRME - Bozor qiymatining balans qiymatiga nisbati|TSHA (tayshagtx.com) - Kapitallashuvning balans qiymatiga nisbati|uniQure (QURE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti MeiraGTx Holdings (MGTX)|Bozor qiymatining balans qiymatiga nisbati Regenxbio|Kapitallashuvning sof aktivlarga nisbati Solid Corp (SLDB)|Bozor kapitallashuvining balans qiymatiga nisbati OCGN|Balans qiymatiga nisbatan bozor kapitallashuvi pacb.com|Benitec Biopharma - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi 4D Molecular Corp FDMT|lexeotx.com (LXEO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati KRRO|EDIT (Editas Medicine) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Silence Therapeutics PLC (SLN)|Kapitallashuvning sof aktivlarga nisbati PRQR (ProQR Therapeutics N.V.)|Balans qiymatiga nisbatan bozor kapitallashuvi codexis.com|Bozor qiymatining balans qiymatiga nisbati Sangamo Therapeutics SGMO|NAUT - Kapitallashuvning sof aktivlarga nisbati|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Generation Bio Co. (GBIO)|BOLD (Boundless Bio, Inc) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati XCUR|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PHIO (RXi Pharmaceuticals)|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|transcodetherapeutics.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BNGO (Bionano Genomics)|Bozor kapitallashuvining balans qiymatiga nisbati Applied DNA Corp APDN|BLUE - Bozor qiymatining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|OMGA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Singular Genomics Systems, Inc. (OMIC)|Kapitallashuvning sof aktivlarga nisbati RGLS|SYRS (Syros Pharmaceuticals, Inc) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|Bozor kapitallashuvining balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)